The estimated Net Worth of Victor A Hartmann is at least $49.4 Million dollars as of 4 June 2007. Victor Hartmann owns over 3,000 units of Vertex Pharmaceuticals stock worth over $47,603,604 and over the last 19 years Victor sold VRTX stock worth over $1,840,291.
Victor has made over 10 trades of the Vertex Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Victor exercised 3,000 units of VRTX stock worth $34,200 on 4 June 2007.
The largest trade Victor's ever made was selling 48,000 units of Vertex Pharmaceuticals stock on 1 August 2006 worth over $1,550,880. On average, Victor trades about 5,699 units every 36 days since 2006. As of 4 June 2007 Victor still owns at least 100,273 units of Vertex Pharmaceuticals stock.
You can see the complete history of Victor Hartmann stock trades at the bottom of the page.
Victor's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE, MA, 02139.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: